Integrating antithrombin and antiplatelet therapies with early invasive management for non-ST-segment elevation acute

Related Experiment Video

Updated: Aug 29, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Abdallah G Rebeiz1, Matthew T Roe, John H Alexander

  • 1Duke Clinical Research Institute and Division of Cardiology, Duke University Medical Center, Durham, North Carolina 27715, USA. rebei001@onyx.dcri.duke.edu

The American Journal of Medicine
|January 13, 2004
PubMed

Insights

Early cardiac catheterization improves outcomes for non-ST-segment elevation acute coronary syndromes. This review examines optimal integration of antithrombotic therapies with early angiography and revascularization for complex cases.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Pharmacology

Background:

  • Non-ST-segment elevation acute coronary syndromes (NSTE-ACS) are a severe manifestation of coronary artery disease.
  • Early cardiac catheterization is proven to enhance clinical outcomes in NSTE-ACS patients.
  • The increasing number of antithrombotic and antiplatelet agents complicates NSTE-ACS management.

Purpose of the Study:

  • To review current evidence on integrating early antithrombotic and antiplatelet therapies.
  • To guide optimal management strategies for NSTE-ACS.
  • To align pharmacologic interventions with early coronary angiography and revascularization.

Main Methods:

  • Systematic review of clinical trials and evidence.
  • Analysis of antithrombotic and antiplatelet agent efficacy.
  • Evaluation of timing for cardiac catheterization and revascularization.

Main Results:

  • Early angiography and revascularization are critical for NSTE-ACS.
  • Antithrombotic and antiplatelet therapies are essential adjuncts to percutaneous coronary intervention.
  • Optimal integration of pharmacologic strategies with invasive procedures requires careful consideration.

Conclusions:

  • Effective management of NSTE-ACS necessitates a coordinated approach.
  • Integrating novel antithrombotic and antiplatelet therapies with early invasive strategies is key.
  • Further research should focus on personalized treatment algorithms for NSTE-ACS.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...